 |
2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline succinic acid |
|---|---|
| Trade Name | |
| Orphan Indication | Huntington disease |
| EU Market Approval | EU |
| EU Designation Date | 2016-07-14 00:00:00 |
| Sponsor | Pfizer Limited |
Related Access Program
| |
2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline succinic acid |
|---|---|
| Trade Name | |
| Orphan Indication | Huntington disease |
| EU Market Approval | EU |
| EU Designation Date | 2016-07-14 00:00:00 |
| Sponsor | Pfizer Limited |